Kilitch Drugs (India) Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
KILITCH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kilitch Drugs (India) Limited has informed the stock exchanges that its trading window will be closed for designated persons and their immediate relatives from Tuesday, 1 July 2025. The window will remain shut until 48 hours after the company declares its financial results for the quarter ended 30 June 2025 (Q1 FY26). The date of the board meeting to approve these unaudited quarterly results will be announced later. This is a routine compliance filing under SEBI's insider trading regulations, typically done before earnings announcements.
This is a standard regulatory filing with no direct impact on shareholders. It signals that the company's Q1 FY26 results are likely to be announced in the coming weeks, which investors should watch for as it may influence short-term stock movement.